SARS-CoV-2 Spike Ectodomain (S1-S2) Antigen from QED BIOSCIENCE INC.
Search, find, compare suppliers for SARS-CoV-2 Spike Ectodomain (S1-S2) Antigen products.
| Edit | |
|---|---|
| Product Name | SARS-CoV-2 Spike Ectodomain (S1-S2) Antigen |
| Description | Recombinant SARS-CoV-2 spike glycoproteins comprised of multiple S1 and S2 domains of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). MW 135 kDa. Since mid-December 2019, the pathogen Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is on the rise. The worldwide spread of the Coronavirus Disease 19 (COVID-19) was declared a pandemic by the WHO on March 11, 2020. Typical clinical symptoms of affected patients are fever, dry cough, shortness of breath, headache and pneumonia. Severe disease progressions lead to respiratory arrest due to alveolar damage, septic shock and/or multiple organ dysfunction or failure and can be fatal. |
| Size | 1mg |
| Concentration | n/a |
| Applications | Immunoassays |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | BA400R03 |
| Price | $1914 |
| Order / More Info | SARS-CoV-2 Spike Ectodomain (S1-S2) Antigen from QED BIOSCIENCE INC. |
| Product Specific References | n/a |
QED BIOSCIENCE INC.
QED BIOSCIENCE INC.
A part of Genovis, Inc.
10919 Technology Place, Suite C
San Diego CA 92127
P: (858) 675-2405
P: (800) 929-2114
F: (858) 592-1509
info@qedbio.com
http://www.qedbio.com
Profile of QED BIOSCIENCE INC.
Return to Products